As of May 2026, BPC-157 is still not formally approved for compounding under 503A
Any human dosing advice or medical claims, which the FTCs health-claims guidance treats as a warning sign
While early preclinical data show promise, its crucial to understand that BPC157 is not federally approved for human use, and nearly all products available to consumers are unregulated research chemicals
It sags and droops, losing its defined contours
Standard Dosing Range In preclinical models, BPC-157 accelerated healing across tendon, muscle, and ligament tissue at doses ranging from 110 mcg/kg/day, making human application at 250750 mcg/day practical and safe. Sikiric et al., Current Pharmaceutical Design Injection vs